Delivery Order SPE2DB22D2206-SPE2DB24FFJ84
Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,461.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 1 mg vials of the pharmaceutical remifentanil. The contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was issued under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that the company holds...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit organization and subsidiary of AmerisourceBergen Corporation. The contract, valued at $2,906.35, is for the supply of 1 mg vials of the pharmaceutical drug remifentanil. The delivery order has an ultimate completion date of March 11, 2024. Additionally, AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1 mg vials of the medication remifentanil. The contract has a ceiling value of $1,417.88 and a period of performance through April 4, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 5 mg vials of the pharmaceutical drug remifentanil. The award has a potential value of $9,336.00 and a completion date of January 29, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as...
- The Defense Logistics Agency awarded a delivery order valued at $3,635.77 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials. This contract, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $2,055.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of August 11, 2025. This is a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,633.40 fixed-price contract is for the supply of Remifentanil 2 mg vials, a specialty pharmaceutical product used in military treatment facilities. The contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,426.20 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of September 4, 2025. This non-set-aside contract employs firm fixed pricing and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,022.40 firm-fixed-price contract is for the supply of 2 mg vials of the drug remifentanil, a potent opioid analgesic. The award has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This contract award is a delivery order worth $5,696.14 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Remifentanil 1 mg vials, a specialty medication used for pain management. The contract has an ultimate completion date of November 28, 2023 and is a firm fixed price arrangement. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...